Centres of Excellence -> Obesity treatment -> Obesity


The centre for obesity is meant not only for the treatment of obese patients, but also patients with cardiovascular and metabolic disorders and individuals exposed to stress and risk factors who do not have cardiovascular disease.

The most recent reports from the World Health Organization (WHO) point towards an enormous prevalence of obesity in the European population, as well as the fact that obesity is the cause of 200.000 cases of cancer and 1.2 million deaths every year. In the adult European population, 59% are overweight or obese, as well as 8% of children younger than 5 years of age. According to the report presented at the European obesity congress, the prevalence of obesity in Europe is greater than any other part of the world, except America. Obesity is associated with a wide range of diseases, including musculoskeletal disorders, diabetes type 2, cardiovascular disease and at least 13 different types of cancer. The WHO report states that the excess of bodily fat leads to early mortality and is the leading risk factor for invalidity. The causes of obesity are much more complex than unhealthy diets and little physical activity and they entail a complex system which is etiologically conditioned by environmental factors and genetic factors.

Obesity is a huge global issue. According to data from WHO, more than 1.9 billion people older than 18 years of age are overweight and 600 million are obese.

Obesity is a complex medical issue, often associated with hypertension, cardiac disease, diabetes, respiratory sleep disorders, depression, arthritis, and others. These conditions lead to the development of cardiometabolic syndrome.

One has to bear in mind that underweight individuals can also suffer from metabolic syndrome which additionally complicates the diagnostic and therapeutic approaches in these patients.

The source of the disorder on a pathophysiological level which is necessary for the development of this syndrome lies in a weakened effect of insulin – the strongest anabolic hormone in the human body which regulates carbohydrate, fat and protein metabolism.

The complexity of a patient with early or full diabetes, metabolism disorder, hyperlipidaemia, hypertension, obesity, and cardiovascular diseases dictates an encompassing multidisciplinary and individualized approach.

Centre specificity

  • Multidisciplinary approach
  • Personalized approach
  • Nutrigenetic analysis

Who are potential candidates?

  • Overweight individuals
  • Individuals with cardiovascular disorders
  • Individuals with diabetes and insulin resistance
  • Individuals with metabolic syndrome
  • Individuals with hypertension

At St. Catherine we provide a professional and individualized approach. Trust and contact our Centre for obesity!

Send Message:

Eu Logo
Hamag-Bicro Logo
europski strukturni i investicijski fondovi
Privacy policy | Cookie Declaration | Sitemap